Best Lutetium-177 Therapy Doctors in Turkey for Australians

Dr. Kezban Berberoglu is a professor of nuclear medicine at Anadolu Medical Center in Istanbul. She completed training at the Johns Hopkins University School of Medicine in Baltimore. Dr. Berberoglu specializes in nuclear oncology and nuclear cardiology. She treats thyroid and prostate cancers using radioisotope therapies. She is a member of the European Association of Nuclear Medicine.

• Performs Lutetium-177 and Actinium-225 therapies for oncology patients.
• Expert in PET-CT imaging using Gallium 68 for oncology cases.
• Member of the Turkish Nuclear Medicine Association cardiology work group.
• Works at an MTQUA Top 10 world hospital affiliated with Johns Hopkins.

Associate Professor Mustafa Solak gained international experience at the University of Texas MD Anderson Cancer Center – arguably the world's most prestigious cancer hospital.

• Completed an oncology fellowship at the Hacettepe University Cancer Institute
• Specialises in systemic treatments for advanced gastrointestinal and prostate malignancies
• Expertise includes modern immunotherapy and targeted interventions for complex cases
• Active member of the Turkish Society of Medical Oncology
• Oversees modern cancer care at Hisar Hospital Intercontinental

Professor Mustafa Serkan Alemdar is a dual-certified specialist in internal medicine and medical oncology at Medical Park Antalya Hospital Complex.

• Completed specialist oncology training at Akdeniz University Faculty of Medicine
• Managed complex cancer cases at Akdeniz University Hospital for over a decade
• Served as a specialist at the Antalya Training and Research Hospital
• Expertise covers both inpatient and outpatient systemic cancer treatments
• Member of the Turkish Society of Medical Oncology

Associate Professor Nail Paksoy is a highly published medical oncologist who specialises in advanced cancer therapies and clinical research at Medipol Bahçelievler University Hospital.

• ESMO Board Certified in Medical Oncology, an international mark of excellence in cancer care
• Investigated Lutetium-177 DOTATATE outcomes in multicentre real-world studies
• Contributed to major clinical trials for Roche, Pfizer, and AstraZeneca
• Authored over 40 international peer-reviewed articles on tumour response and survival
• Holds academic leadership as an Associate Professor of Medical Oncology

Prof. Dr. Gül Alço is a radiation oncologist with about 27 years of experience. She treats breast, lung, prostate, gastrointestinal, gynecologic, central nervous system, head and neck, soft tissue, and bone cancers with radiotherapy.

Her expertise includes adaptive radiotherapy and radiosurgery. She uses advanced radiation techniques to provide personalized, evidence-based care in a multidisciplinary, patient-centered setting.

Prof. Dr. Abdullah Sakin is a professor of medical oncology. He treats solid tumors, including lung, breast, gastrointestinal, genitourinary, gynecologic, head and neck cancers, and melanoma.

He delivers personalized, evidence-based care. His treatments include chemotherapy, targeted therapy, immunotherapy, hormone therapy, and precision oncology. He has authored more than 200 scientific publications and takes part in international clinical research. This work advances patient-centered cancer care.